Ticker League

Free Cash Flow for Regeneron Pharmaceuticals (REGN)

As of · Reported

Metric

Latest period

$4.16B

YoY change

+11.3%

5Y CAGR

+15.3%

Peak year (2021)

$6.53B

Free Cash Flow history chart for Regeneron Pharmaceuticals (REGN) from 1991 to 2025

Latest: $4.08B

Free Cash Flow growth chart for Regeneron Pharmaceuticals (REGN) from 1991 to 2025

Latest: +11.3%

Free Cash Flow history table for Regeneron Pharmaceuticals (REGN) from 1991 to 2025

  • 2025$4.08B+11.3%
  • 2024$3.66B-0.1%
  • 2023$3.67B-17.1%
  • 2022$4.42B-32.2%
  • 2021$6.53B+225.9%
  • 2020$2.00B+0.2%
  • 2019$2.00B+10.4%
  • 2018$1.81B+75.2%
  • 2017$1.03B+6.2%
  • 2016$974.00M+49.2%
  • 2015$652.85M+55.7%
  • 2014$419.43M-3.0%
  • 2013$432.27M-448.7%
  • 2012−$123.95M-37.7%
  • 2011−$198.90M+5846.2%
  • 2010−$3.35M-98.0%
  • 2009−$169.55M+36.8%
  • 2008−$123.94M-1488.6%
  • 2007$8.93M-56.0%
  • 2006$20.26M-157.5%
  • 2005−$35.26M+52.8%
  • 2004−$23.08M-35.5%
  • 2003−$35.79M-75.3%
  • 2002−$144.89M+121.1%
  • 2001−$65.54M+90.5%
  • 2000−$34.41M+76.4%
  • 1999−$19.50M+47.7%
  • 1998−$13.20M+61.0%
  • 1997−$8.20M-71.6%
  • 1996−$28.90M+34.4%
  • 1995−$21.50M-21.5%
  • 1994−$27.40M-32.0%
  • 1993−$40.30M+108.8%
  • 1992−$19.30M+147.4%
  • 1991−$7.80M—

Free Cash Flow values are taken from Regeneron Pharmaceuticals's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About Free Cash Flow at Regeneron Pharmaceuticals (REGN)

Free Cash Flow for Regeneron Pharmaceuticals (REGN): headline value $4.16B · YoY +11.3%. Annual and quarterly series, chart, and tables are below.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

Regeneron Pharmaceuticals (REGN) most recent annual free cash flow stands at $4.08B (2025) – grew 11.3% year-over-year.

Regeneron Pharmaceuticals free cash flow has grown on net over the period, with a +15.3% compound annual growth rate over 2020–2025 (5 years).

Regeneron Pharmaceuticals free cash flow plunged from $6.53B in 2021 to $4.08B in 2025, a 37.5% drawdown.

$6.53B stands as the all-time-high annual free cash flow, posted in 2021, against a low of −$198.90M during 2011.

Regeneron Pharmaceuticals Free Cash Flow by Year

Regeneron Pharmaceuticals Free Cash Flow 2025: $4.08B

In 2025, Regeneron Pharmaceuticals reported free cash flow of $4.08B, grew 11.3% from 2024.

Regeneron Pharmaceuticals Free Cash Flow 2024: $3.66B

Regeneron Pharmaceuticals free cash flow in 2024 was $3.66B, edged down 0.1% below 2023.

Regeneron Pharmaceuticals Free Cash Flow 2023: $3.67B

2023's free cash flow for Regeneron Pharmaceuticals came in at $3.67B, declined 17.1% below 2022.

Regeneron Pharmaceuticals Free Cash Flow 2022: $4.42B

Regeneron Pharmaceuticals posted free cash flow of $4.42B in 2022, plunged 32.2% below 2021.

Regeneron Pharmaceuticals Free Cash Flow 2021: $6.53B

Regeneron Pharmaceuticals free cash flow in 2021 was $6.53B.

See more financial history for Regeneron Pharmaceuticals (REGN).

Sector peers by Free Cash Flow

Healthcare peers of Regeneron Pharmaceuticals (REGN), ranked by their latest free cash flow

Frequently asked questions

Regeneron Pharmaceuticals (REGN) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation